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http://dx.doi.org/10.1016/j.kjms.201
1607-551X/Copyright ª 2014, KaohsiuAbstract Our aim was to compare the outcomes and satisfaction rates of men undergoing
penile prostheses implantation (PPI) secondary to radical prostatectomy (RP) and other causes
of vasculogenic erectile dysfunction (ED). A total of 142 patients, of whom 60 underwent PPI
due to ED following RP (Group 1) and 82 underwent PPI due to ED with other vasculogenic
causes (Group 2) were included in this study. The preoperative erectile status was evaluated
with the International Index of Erectile Function (IIEF). The satisfaction of patients and part-
ners were evaluated by a telephone interview using Erectile Dysfunction Inventory of Treat-
ment Satisfaction (EDITS) questionnaire and Erectile Dysfunction Inventory of Treatment
Satisfaction Partner Survey. Preoperative mean IIEF scores were significantly lower in Group
1 (17.5  6.4 vs. 24.2  5.1, p Z 0.01). For Groups 1 and 2, the mean EDITS scores of the pa-
tients were 58  10 and 71  8, respectively, and that for the partners were 46  8 and 65  7,
respectively. Group 1 had significantly lower scores both for the EDITS and the EDITS Partner
Survey (p Z 0.03, p Z 0.01, respectively). Patients who had undergone RP and their partners
were found to have lower satisfaction rates compared to patients with other causes of vascu-
logenic ED who had penile implant surgery. From this point of view, it is important to know the
patient’s expectations about the treatment outcomes and a preoperative psychological and
sexual counseling should be managed for possible treatment alternatives after RP.
Copyright ª 2014, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.eclare no conflicts of interest.
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Table 1 Intraoperative and postoperative complications.
Complications RP Vasculogenic p
Intraoperative, total 4 (6.6) 3 (3.6) 0.456
Corporeal crossover 2 1
Corporeal perforation 1 1
Urethral perforation 1 1
Postoperative, total 5 (8.3) 8 (9.7) 0.772
Infection 2 2
Erosion 1 3
Mechanical
complications
2 3
Data are presented as n (%).
RP Z radical prostatectomy.
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Erectile dysfunction (ED) is the persistent inability to attain
and maintain a sufficient erection for a satisfactory sexual
performance [1]. Although ED is a benign disorder, it may
affect physical and psychosocial health and may have a
significant impact on the quality of life (QoL) of sufferers
and their partners [2]. The prevalence of ED is increasing as
the life expectancy of men continues to increase. It is
estimated that 20e30% of adult men suffer from at least
one episode of sexual dysfunction in their lives [1].
ED shares common risk factors with cardiovascular dis-
orders such as metabolic syndrome, smoking, obesity, and
hypercholesterolemia. Also, ED is a common unwanted
complication of radical prostatectomy (RP) in any form
(open, laparoscopic, or robotic) affecting health-related
QoL of patients. It is reported that 25e75% of men expe-
rience postoperative ED [3]. Phosphodiesterase type 5
(PDE5) inhibitors serve as the first-line treatment for men
experiencing ED after RP. The choices for second-line
treatment are vacuum devices, intracavernosal vasoactive
injections, or transurethral prostaglandin E1, which are
associated with significant discontinuation rates. When
conservative therapy fails or when the patient refuses
conservative treatment, penile prosthesis implantation
(PPI) is the gold standard of treatment.
Overall, satisfaction rates for patients and partners are
high after PPI [4]. Although the satisfaction rates have been
well studied for different types of penile prostheses [5e8],
the satisfaction rates in terms of the etiological factor has
not been well studied. In this study, we aimed to compare
the outcomes and satisfaction rates of men undergoing PPI
secondary to RP or other causes of vasculogenic ED.
Materials and methods
Between August 2001 and June 2012, 257 men with ED
underwent PPI at our institution. The exclusion criteria
were: known neurological disorder, Peyronie’s disease,
moderate to severe urinary incontinence, those without a
regular partner, and patients who had undergone secondary
implant surgery. All patients had completed a minimum
1 year follow-up period after PPI. Institutional Review
Board approval was obtained from the Local Ethics Com-
mittee (Izmir Training and Research Hospital): Number 19-
28/2; January 24, 2013. Group 1 comprised 60 patients who
underwent PPI due to ED following RP, and Group 2
comprised 82 patients who underwent PPI due to ED with
other vasculogenic causes. The patients who had under-
gone bilateral nerve-sparing RP were followed-up for at
least 2 years before PPI. Other patients were evaluated for
PPI according to their response to first- and second-line
treatment and on patients’ demands. The most common
type of penile prosthesis implanted were AMS 600-650 fol-
lowed by Mentor Acu-Form, AMS Ambicor, AMS 700 CX, AMS
Ultrex, and AMS Ultrex plus.
All operations were performed by two experienced sur-
geons in a single center under intravenous antibiotic pro-
phylaxis and spinal anesthesia. The skin of the surgical field
was scrubbed with povidoneeiodine solution for 10 mi-
nutes. In most of the cases a single penoscrotal incision wasused; an infrapubic incision was rarely required, particu-
larly for three-piece inflatable prostheses. Intraoperative
complications were recorded.
Data about preoperative assessment and complications
were obtained retrospectively from the patients’ records.
Complications are summarized in Table 1. The preoperative
erectile status was evaluated with the international index of
erectile function (IIEF). The satisfaction of patients and
partners were evaluated by a telephone interview using the
Erectile Dysfunction Inventory of Treatment Satisfaction
(EDITS) questionnaire and Erectile Dysfunction Inventory of
Treatment Satisfaction Partner Survey [9]. The patientswere
also asked if they would undergo the same operation again
and if they would recommend this treatment to friends.
Statistical analysis
All statistical analyses were performed using SPSS software
version 17.0 (SPSS Inc., Chicago, IL, USA). Categorical var-
iables were analyzed using the c2 or Fisher exact test and
continuous variables were analyzed using the Man-
neWhitney U test. Comparative differences were consid-
ered statistically significant when p < 0.05.
Results
After the exclusion of patients with whom we could not
have contact and those who refused to respond to the
survey, a total of 142 patients were enrolled. Patients in
Group 1 and Group 2 had a mean age of 57 years
(40e76 years) and 60 years (48e74 years), respectively,
without a statistically significant difference (p Z 0.771).
Mean duration of time with ED in the preimplantation
period was 29.4  22.7 months and 51.4  36.7 months in
Groups 1 and Group 2, respectively (p < 0.001). In Group 1
and Group 2, 85% and 82%, respectively, of the patients had
tried PDE5 inhibitors, and 28% and 24%, respectively, had
tried intracavernosal injections before PPI. None of the
patients had previously tried a vacuum in both groups. The
most common intraoperative complications were corporeal
crossover, corporeal perforation, and urethral perforation.
In the case of urethral perforation, the patient was
catheterized and the operation was postponed for a second
session. The complications are summarized in Table 1.
There was no statistically significant difference between
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complication rates (p Z 0.456, p Z 0.772, respectively).
Mean follow-up was 34 months (range: 13e131 months).
Preoperative mean IIEF scores were significantly lower in
Group 1 (17.5  6.4 vs. 24.2  5.1 in Group 2, p Z 0.01).
For Group 1 and Group 2, the mean EDITS scores of the
patients were 58  10 and 71  8, respectively, and those
for the partners were 46  8 and 65  7, respectively.
Group 1 had significantly lower scores both for the EDITS
and EDITS Partner Survey (p Z 0.03 and p Z 0.01,
respectively). The satisfaction rates of the patients and
partners at 5 years and 10 years were lower compared to
those in the first two years. The mean frequency of sexual
intercourse per month was 4.2 (range; 1e19) and 6.1
(range: 2e17) for Group 1 and Group 2, respectively.
Eighty-five percent of the patients reported that they
would have the surgery performed again and would
recommend prosthetic surgery to their friends. Patient
characteristics and outcomes are summarized in Table 2.Discussion
PPI is the most effective option to obtain an artificial
erection satisfactory for sexual intercourse for patients
with refractory ED. The most important end-point of PPI
surgery is to achieve the highest patient and partner
satisfaction with the lowest complication rates. Although
the satisfaction rates have been well studied for different
types of penile prostheses [5e8], the satisfaction rates in
terms of the etiological factor have not been well studied.Table 2 Patient characteristics and outcomes of both
groups.
Characteristics RP Vasculogenic p*
Patients, n 60 82
Age (y) 57 (40e76) 60 (48e74) 0.771
Follow-up (mo) 34.9  24.5 34.1  24.3 0.812
Pre-op IIEF score 17.5  6.4 24.2  5.1 0.01
Previous ED treatments
Oral treatment 51 (85.0) 68 (82.9) 0.740
ICI 17 (28.3) 20 (24.3) 0.597
Duration of ED until
surgery (mo)
29.4  22.7 51.4  36.7 <0.001
Type of prosthesis
Malleable 30 (50.0) 44 (53.6) 0.666
Inflatable-2p 28 (46.6) 35 (42.6) 0.637
Inflatable-3p 2 (3.4) 3 (3.8) 0.645
EDITS score
Patients’ score 58  10 71  8 0.03
Partners’ score 46  8 65  7 0.01
Frequency of sexual
intercourse (per mo)
4.2 (1e19) 6.1 (2e17) 0.07
Data are presented as n (%), mean (range), or mean  SD.
ED Z erectile dysfunction; EDITS Z Erectile Dysfunction
Inventory of Treatment Satisfaction; ICI Z intercavernosal
injection; IIEF Z International Index of Erectile Function;
Pre-op Z preoperative; RP Z radical prostatectomy;
SD Z standard deviation.
* The statistically significant values are in bold font.In this study we aimed to establish whether the etiology is
related to the outcomes of PPI surgery.
Penile prostheses are subject to continuous development
and have gained better mechanical reliability and safety in
recent decades [10], but device-related complications
together with the well-known complications of PPI can still
occur [11,12]. With the evolvement of inflatable penile
prostheses with infection-retardant coating, the infection
rates have decreased over time. In a meta-analysis con-
ducted by Mandava et al. [13], the incidence rates for
infection were reported as 2.32% and 0.89% for noncoated
prostheses and antibiotic-impregnated prostheses, respec-
tively. The infection rate was 3% in our study. Mechanical
reliability of penile prosthesis has increased over time. As
stated in previous reports, mechanical failure is more
common with former prostheses, which was found to be
independent from the etiology as in our study [11,12,14].
Many authors have reported results concerning the pa-
tients’ and their partners’ satisfaction using different penile
prostheses. Salama reported satisfaction rates of 70% and
57% for patients and partners, respectively, using malleable
penile prostheses in 50 cases [5]. In a prospective analysis of
22 patients, Falcone et al. reported satisfaction rates of
86.4% and 52.6% for patients and partners, respectively, with
the AMS Spectra penile prosthesis. Several studies have
concluded that inflatable penile prostheses have high satis-
faction rates for both patients and their partners [6e8,15].
Waiting for a minimum of 2 years prior to PPI after
nerve-sparing RP is generally recommended [16]. In this
period, first- and second-line treatments should be advised
to patients. In non-nerve-sparing RP, PPI may be offered at
any time after failure of medical treatment. Even simul-
taneous placement of penile prosthesis and RP is feasible,
with high satisfaction rates [17].
In a prospective study it was shown that the IIEF and
EDITS scores after inflatable PPI were found to gradually
increase until 9e12 months, and reached a plateau after-
wards [18]. We included patients with a minimum 1 year
follow-up in our study.
Although the satisfaction rates have been well studied
according to the type of penile prosthesis, less is known
about satisfaction rates of PPI in terms of the etiology.
Akin-Olugbade et al. [19] have reported that penile pros-
thesis surgery has lower satisfaction rates in patients with
Peyronie’s disease, with a body mass index > 30 or for those
who have had previous RP. Menard et al. [20] have found
significantly lower orgasmic function after PPI in patients
with RP compared to those with other causes of vasculo-
genic ED. We found that, after PPI, overall satisfaction
rates for RP patients and their partners were significantly
lower than those with other causes of vasculogenic ED. Our
results are consistent with the previous studies. These
overall high satisfaction rates may be attributed to the
methodology, and the study groups composed of patients
that wish to use the prostheses.
Sexual dysfunction has been found to have the most
negative impact on QoL of patients after RP [21], which can
be due to several factors, including perceptions of in-
adequacy, performance anxiety and depression in each
member of the couple, overly enthusiastic expectations,
and partner physical/emotional readiness to resume active
sex [22]. One study has concluded that men with recently
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tions of sexual outcomes, whereas in reality, most survivors
experience severe and lasting sexual dysfunction and
dissatisfaction [23]. The negative impact of oncological
anxiety on the satisfaction rates patients and their partners
after PPI is also important. One study has reported that the
level of spousal distress arising from a patient’s sexual
symptoms after primary prostate cancer treatment is also
associated with the partner’s level of satisfaction with the
treatment outcome [3]. Besides, psychological distress
from decreased orgasm intensity may also negatively affect
the satisfaction rates [24].
Our study had some limitations. The attempt to ho-
mogenize the groups resulted in a small sample size. We did
not assess the psychological distress of patients and their
partners. Although the telephone survey to collect data can
be thought as a limitation, this facilitated our work, espe-
cially for collecting data from the partners, because of the
traditional characteristics of our country, women shy away
to answer these questions face to face.
In conclusion, patients who underwent RP and their
partners were found to have lower satisfaction rates
compared to patients with other causes of vasculogenic ED
who had penile implant surgery. From this point of view, it
is important to know the patient’s expectations about the
treatment outcomes, and preoperative psychological and
sexual counseling should be managed for possible treat-
ment alternatives after RP.
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